Treatment Compliance with Fixed-Dose Combination of Vildagliptin/Metformin in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Metformin Monotherapy: A 24-Week Observational Study

Treatment Compliance with Fixed-Dose Combination of Vildagliptin/Metformin in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Metformin Monotherapy: A 24-Week Observational Study

Objective. To evaluate the differences in treatment compliance with vildagliptin/metformin fixed-dose versus free-dose combination therapy in patients with type 2 diabetes mellitus (T2DM) in Greece. Design. Adult patients with T2DM, inadequately controlled with metformin monotherapy, (850 mg bid), p...

Full description

Saved in:

Bibliographic Details
Main Authors:	Grigorios Rombopoulos, Magdalini Hatzikou, Athanasios Athanasiadis, Moyses Elisaf
Format:	Article
Language:	English
Published:	Wiley 2015-01-01
Series:	International Journal of Endocrinology
Online Access:	http://dx.doi.org/10.1155/2015/251485
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Results of a clinical trial of the efficacy and safety of vildagliptin and metformin fixed combination in real clinical practice in Russia (MASTER study)
by: N. A. Demidov, et al.
Published: (2021-02-01)

Efficiency and safety of transfer of type 2 diabetes patients inadequately controlled on metformin alone to combined therapy with metformin and diabeton MB
by: Alexander Sergeevich Ametov, et al.
Published: (2009-12-01)

Effects Of Metformin And Myo-Inositol In Combination Versus Metformin As Monotherapy On The Metabolic Profile Of Polycystic Ovarian Syndrome Patients With Infertility
by: Hira Ehsan Khattak, et al.
Published: (2024-09-01)

A prospective, multicentre study evaluating safety and efficacy of a fixed dose combination of Remogliflozin etabonate, Vildagliptin, and Metformin in Indian patients with type 2 diabetes mellitus (Triad-RMV)
by: Prabhat K Agarwal, et al.
Published: (2024-12-01)

The Cost of Managing Type 2 Diabetes Mellitus in Greece: A Retrospective Analysis of 10-Year Patient Level Data “The HERCULES Study”
by: Ilias Migdalis, et al.
Published: (2015-01-01)

HPLC and HPTLC methods for simultaneous quantification of Metformin hydrochloride, Vildagliptin and Dapagliflozin propanediol with comparative evaluation by greenness and whiteness assessment tools
by: Krinal Barot, et al.
Published: (2025-06-01)

Blue applicability grade index assessment and response surface modelling to synchronous determination of metformin hydrochloride, vildagliptin and dapagliflozin propanediol monohydrate by HPTLC method
by: Pintu Prajapati, et al.
Published: (2025-02-01)

Effects of metformin, acarbose, and sitagliptin monotherapy on gut microbiota in Zucker diabetic fatty rats
by: Wei Liu, et al.
Published: (2019-05-01)

Upadacitinib as monotherapy in patients with rheumatoid arthritis and prior inadequate response to methotrexate: results at 260 weeks from the SELECT-MONOTHERAPY randomised study
by: Josef S Smolen, et al.
Published: (2025-05-01)

Comparison of Exenatide and Metformin Monotherapy in Overweight/Obese Patients with Newly Diagnosed Type 2 Diabetes
by: Jia Liu, et al.
Published: (2017-01-01)

The Toxicity Effects of Metformin and the Bioremediation of Metformin in Aquatic Plant Duckweed
by: Bing Han, et al.
Published: (2025-06-01)

Formulation and Optimization of Monolithic Fixed-Dose Combination of Metformin HCl and Glibenclamide Orodispersible Tablets
by: Anteneh Belayneh, et al.
Published: (2020-01-01)

Influencing factors for treatment escalation from metformin monotherapy in youth-onset type 2 diabetes in Northern Taiwan
by: Yi-Hsuan Chou, et al.
Published: (2024-09-01)

PLEYOTROPIC EFFECTS OF METFORMIN
by: L. Ju. Morgunov
Published: (2015-01-01)

Metformin and cancer mortality
by: Lev Mikhaylovich Bershteyn
Published: (2010-09-01)

Cardiovascular Effects of Metformin
by: B. T. Kurmanbekova, et al.
Published: (2022-03-01)

A Multicenter, Randomized, Open-Label Study to Compare the Effects of Gemigliptin Add-on or Escalation of Metformin Dose on Glycemic Control and Safety in Patients with Inadequately Controlled Type 2 Diabetes Mellitus Treated with Metformin and SGLT-2 Inhibitors (SO GOOD Study)
by: Hae Jin Kim, et al.
Published: (2024-01-01)

Monotherapy with Metformin versus Sulfonylureas and Risk of Cancer in Type 2 Diabetic Patients: A Systematic Review and Meta-Analysis
by: Abraham Nigussie Mekuria, et al.
Published: (2019-01-01)

Metformin for the chemoprophylaxis of cancer: an update systematic review about the role of metformin in cancer prevention.
by: Mirella Nardo, et al.
Published: (2020-01-01)

Metformin remodels the myelin landscape
by: Bandy Chen
Published: (2026-03-01)

Chemoprevention of Gastric Cancer: Metformin
by: Young-Il Kim, et al.
Published: (2017-12-01)

Metformin in metabolic syndrome treatment
by: V. I. Podzolkov, et al.
Published: (2005-06-01)

Evaluation of fixed dose combination of glimepiride and metformin in patients with type 2 diabetes. Results of Russian observational study
by: Natalya Vladislavovna Zaytseva, et al.
Published: (2015-06-01)

Effect of metformin on olanzapine-induced weight gain: A 12-week randomised open-label study
by: G. Chetan Kumar, et al.
Published: (2025-01-01)

Simultaneous HPLC of Metformin, Glipizide and Gliclazide, and Metformin Uptake and Protection of HEI-OC1 from Hyperglycaemia
by: Ahmed Gedawy, et al.
Published: (2024-11-01)

Risk of Death and Heart Failure among Patients with Type 2 Diabetes Treated by Metformin and Nonmetformin Monotherapy: A Real-World Study
by: Siyao He, et al.
Published: (2021-01-01)

Comparative efficacy and safety of antidiabetic drug regimens added to metformin monotherapy in patients with type 2 diabetes: a network meta-analysis.
by: Elizabeth S Mearns, et al.
Published: (2015-01-01)

Treatment pathways in people with type 2 diabetes mellitus: a nationwide cohort study of new users of metformin monotherapy in New Zealand
by: Simon Horsburgh, et al.
Published: (2021-08-01)

Use of metformin in treatment of dengue fever
by: Zainab Irfan, et al.
Published: (2025-01-01)

Enhancing Diabetes Treatment: Comparing Pioglitazone/Metformin with Dapagliflozin Versus Basal Insulin/Metformin in Type 2 Diabetes
by: Lin Y, et al.
Published: (2025-03-01)

WCN24-2589 Metformin Misuse Unveiled: Navigating Severe Lactic Acidosis in the Spectrum of Eating Disorders
by: Mayssaa Hoteit, et al.
Published: (2024-04-01)

Efficacy and Safety of Pioglitazone Add‐On in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin: A Systematic Review and Meta‐Analysis of Randomised Controlled Trials
by: Ubaid Khan, et al.
Published: (2025-05-01)

Anniversary of METFORMIN: in 2007 - 50 years in use
by: Editorial team Diabetes Mellitus
Published: (2007-12-01)

Metformin in the treatment of colorectal cancer and neuroendocrine tumours
by: Karolina Daniłowska, et al.
Published: (2024-08-01)

Metformin: A Potential Drug for COVID-19
by: Anjali Devi Bettadapura Shankara Rao, et al.
Published: (2024-04-01)

Gestational Diabetes Management and Outcomes in South Jordan: Metformin Alone vs. Metformin-Insulin Therapy, A Retrospective Cohort Study
by: Ahlam M. Al-Kharabsheh, et al.
Published: (2024-11-01)

Efficacy and Tolerability of Travoprost 0.004%/Timolol 0.5% Fixed-Dose Combination for the Treatment of Primary Open-Angle Glaucoma or Ocular Hypertension Inadequately Controlled with Beta-Blocker Monotherapy
by: Simon Fabian Lerner, et al.
Published: (2017-01-01)

Additive Effect of Highly Aspherical Lenslet Target Spectacles to Children Inadequately Controlled by Atropine Monotherapy
by: Bryan Xiangrong Sim, MMed, FRCOphth, et al.
Published: (2025-07-01)

Effectiveness of triple fixed-dose combination in patients with inadequate blood pressure control
by: E. V. Zbyshevskaya, et al.
Published: (2022-02-01)

A Post Hoc Analysis of the CKD-FIX Study Analyzing the Association Between Metformin Usage and Estimated GFR Decline
by: Isabelle Kitty Stanley, et al.
Published: (2024-05-01)